159 related articles for article (PubMed ID: 33938370)
21. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules.
Taylor CV; Taupenot L; Mahata SK; Mahata M; Wu H; Yasothornsrikul S; Toneff T; Caporale C; Jiang Q; Parmer RJ; Hook VY; O'Connor DT
J Biol Chem; 2000 Jul; 275(30):22905-15. PubMed ID: 10781584
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide biosynthesis during normal pregnancy and pregnancy complicated by preeclampsia.
Hodžić J; Izetbegović S; Muračević B; Iriškić R; Štimjanin Jović H
Med Glas (Zenica); 2017 Aug; 14(2):211-217. PubMed ID: 28786966
[TBL] [Abstract][Full Text] [Related]
23. The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease.
Höglund K; Häggström J; Höglund OV; Stridsberg M; Tidholm A; Ljungvall I
Acta Vet Scand; 2020 Aug; 62(1):43. PubMed ID: 32758260
[TBL] [Abstract][Full Text] [Related]
24. The correlation between renal function and systolic or diastolic blood pressure in severe preeclamptic women.
Seow KM; Tang MH; Chuang J; Wang YY; Chen DC
Hypertens Pregnancy; 2005; 24(3):247-57. PubMed ID: 16263597
[TBL] [Abstract][Full Text] [Related]
25. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies.
Wu Y; Xiong X; Fraser WD; Luo ZC
Am J Hypertens; 2012 Jun; 25(6):711-7. PubMed ID: 22378034
[TBL] [Abstract][Full Text] [Related]
26. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
27. Increased serum ghrelin in preeclampsia: is ghrelin a friend or a foe?
Erol O; Ellidağ HY; Ayık H; Bülbül GA; Derbent AU; Kulaksızoğlu S; Yılmaz N
Ginekol Pol; 2016; 87(4):277-82. PubMed ID: 27321099
[TBL] [Abstract][Full Text] [Related]
28. Elevated serum-soluble Fas in preeclampsia: correlation with clinical, laboratory, and Doppler parameters.
El-Sherbiny W; Soliman A; El-Mazny A
Hypertens Pregnancy; 2011; 30(2):221-30. PubMed ID: 21250890
[TBL] [Abstract][Full Text] [Related]
29. [Serum uric acid levels and risk of developing preeclampsia].
Corominas AI; Balconi SM; Palermo M; Maskin B; Damiano AE
Medicina (B Aires); 2014; 74(6):462-71. PubMed ID: 25555007
[TBL] [Abstract][Full Text] [Related]
30. Serum kallistatin level is decreased in women with preeclampsia.
Güralp O; Tüten N; Gök K; Hamzaoglu K; Bulut H; Schild-Suhren M; Malik E; Tüten A
J Perinat Med; 2020 Aug; 49(1):60-66. PubMed ID: 32866127
[TBL] [Abstract][Full Text] [Related]
31. The Role of Catestatin in Preeclampsia.
Bralewska M; Pietrucha T; Sakowicz A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473713
[TBL] [Abstract][Full Text] [Related]
32. Persistence of cardiovascular risk factors in women with previous preeclampsia: a long-term follow-up study.
Aykas F; Solak Y; Erden A; Bulut K; Dogan S; Sarli B; Acmaz G; Afsar B; Siriopol D; Covic A; Sharma S; Johnson RJ; Kanbay M
J Investig Med; 2015 Apr; 63(4):641-5. PubMed ID: 25738648
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of serum levels of soluble vascular endothelial (sVE)-Cadherin in early- and late-onset preeclampsia serum sVE-Cadherin levels in preeclampsia.
Acikgöz AS; Gök K; Tüten A; Kaya B; Hamzaoğlu K; Kolomuç Gayretli T; Malik E; Güralp O
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2326304. PubMed ID: 38499386
[TBL] [Abstract][Full Text] [Related]
34. Serum survivin is decreased in women with preeclampsia.
Güralp O; Gök K; Tüten N; Hamzaoglu K; Makul M; Oner YO; Bulut H; Schild-Suhren M; Malik E; Tüten A
Hypertens Pregnancy; 2021 May; 40(2):144-151. PubMed ID: 34014801
[No Abstract] [Full Text] [Related]
35. Elevated circulating thrombomodulin in severe preeclampsia.
Hsu CD; Iriye B; Johnson TR; Witter FR; Hong SF; Chan DW
Am J Obstet Gynecol; 1993 Jul; 169(1):148-9. PubMed ID: 8392790
[TBL] [Abstract][Full Text] [Related]
36. The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol.
Durakoğlugil ME; Ayaz T; Kocaman SA; Kırbaş A; Durakoğlugil T; Erdoğan T; Çetin M; Şahin OZ; Çiçek Y
Anatol J Cardiol; 2015 Jul; 15(7):577-85. PubMed ID: 25538000
[TBL] [Abstract][Full Text] [Related]
37. Visfatin serum levels are increased in women with preeclampsia: a case-control study.
Zorba E; Vavilis D; Venetis CA; Zournatzi V; Kellartzis D; Tarlatzis BC
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1668-73. PubMed ID: 22272940
[TBL] [Abstract][Full Text] [Related]
38. Serum amphiregulin and cerebellin-1 levels in severe preeclampsia.
Güler Ö; Özer A; Seyithanoğlu M; Yaman FN; Şahpaz Kurşun HN
J Matern Fetal Neonatal Med; 2021 Sep; 34(17):2863-2868. PubMed ID: 31630583
[TBL] [Abstract][Full Text] [Related]
39. Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension.
Meng L; Ye XJ; Ding WH; Yang Y; Di BB; Liu L; Huo Y
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):643-7. PubMed ID: 21508845
[TBL] [Abstract][Full Text] [Related]
40. Raised serum TNF-alpha, blood sugar and uric acid in preeclampsia in third trimester of pregnancy.
Gulati R
JNMA J Nepal Med Assoc; 2005; 44(158):36-8. PubMed ID: 16554868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
